We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Innovative New Technology to Provide Plastic-Exterior Components with Glass Interior, Presented at AACC 2015

By Paul Mills
Posted on 24 May 2016
Print article
A breakthrough technology now enables the manufacture of plastic exterior components with complete interior coverage of pure glass. Attendees of the 2015 AACC Meeting & Clinical Lab Expo (July 26–30; Atlanta, GA, USA) are invited to visit Booth 3615 to learn about how the broad range of products envisioned from the application of this technology could provide numerous benefits, including for clinical science.

“This breakthrough will allow us to provide products that have the best of both worlds: the lightweight, break resistant properties of plastic with the barrier qualities and inert inner surface of pure glass,” said Wayne Brinster, president and CEO of Wheaton (Millville, NJ, USA), a leading provider of innovative plastic- and glass-based solutions for research, diagnostic, and specialty pharmaceutical industries. “For 126 years Wheaton has been an innovator in glass as well as plastic for laboratories. Customers look to us to solve their needs and this technology will allow us to develop purpose-built products that blend the features of both glass and plastic into a single innovative solution,” he added.

The technology is broadly applicable across the bulk of the company’s product range. Benefits of a pure glass interior include the elimination of compounds from the container contaminating the contents as occasionally occurs with plastic products, while also providing an interior surface with less vapor transmission and higher resistance to solvents. This is combined with the benefit of the lightweight plastic exterior protecting the glass from cracking and breakage.

“We understand that there are many applications where using a plastic product or a glass product are appropriate,” said Mr. Brinster, “But we also know that there are applications where having both materials in one product has long been needed. These premium products will fill those needs as none have been available until now. The tooling needed for broad production of the glass and plastic products is being built now and we expect to begin delivery of these products to customers in the fourth quarter this year.”

Related Links:

Wheaton
American Association for Clinical Chemistry (AACC)
AACC 2015 Annual Meeting & Clinical Lab Expo


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Silver Member
Verification Panels for Assay Development & QC
Seroconversion Panels

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.